Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Hilden

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Obstetrics and Gynecology|September 14, 2020
Improved Outcomes With an Enhanced Recovery Approach to Cesarean DeliveryLuciana Mullman, Patrick Hilden, Jan Goral, et al.
Blood|March 12, 2015
Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphomaCraig S Sauter, Matthew J Matasar, Jessica Meikle, et al.
British Journal of Haematology|February 6, 2016
The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 monthsMatthew A Lunning, Jocelyn C Migliacci, Patrick Hilden, et al.
Blood|June 26, 2014
A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myelomaNikoletta Lendvai, Patrick Hilden, Sean Devlin, et al.
Blood Advances|January 15, 2020
Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulinIoannis Politikos, Jessica A Lavery, Patrick Hilden, et al.
Pediatric Blood & Cancer|July 17, 2018
Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: A pilot studyDanielle Novetsky Friedman, Patrick Hilden, Chaya S Moskowitz, et al.
Leukemia Research|August 30, 2016
Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemiaJustin M Watts, Bogdan Dumitriu, Patrick Hilden, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in OncologyLaurent Dercle, Dana E Connors, Ying Tang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2019
Presalvage International Staging System Stage and Other Important Outcome Associations in CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple MyelomaAdam R Bryant, Patrick Hilden, Sergio Giralt, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2013
A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastasesCameron Brennan, T Jonathan Yang, Patrick Hilden, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Obstetrics and Gynecology|September 14, 2020
Improved Outcomes With an Enhanced Recovery Approach to Cesarean DeliveryLuciana Mullman, Patrick Hilden, Jan Goral, et al.
Blood|March 12, 2015
Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphomaCraig S Sauter, Matthew J Matasar, Jessica Meikle, et al.
British Journal of Haematology|February 6, 2016
The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 monthsMatthew A Lunning, Jocelyn C Migliacci, Patrick Hilden, et al.
Blood|June 26, 2014
A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myelomaNikoletta Lendvai, Patrick Hilden, Sean Devlin, et al.
Blood Advances|January 15, 2020
Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulinIoannis Politikos, Jessica A Lavery, Patrick Hilden, et al.
Pediatric Blood & Cancer|July 17, 2018
Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: A pilot studyDanielle Novetsky Friedman, Patrick Hilden, Chaya S Moskowitz, et al.
Leukemia Research|August 30, 2016
Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemiaJustin M Watts, Bogdan Dumitriu, Patrick Hilden, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in OncologyLaurent Dercle, Dana E Connors, Ying Tang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2019
Presalvage International Staging System Stage and Other Important Outcome Associations in CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple MyelomaAdam R Bryant, Patrick Hilden, Sergio Giralt, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2013
A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastasesCameron Brennan, T Jonathan Yang, Patrick Hilden, et al.
Pageof 5